Translating Basic Research to the Patient’s Bedside
Denis Lacombe, EORTC Director General, Emile Voest, Director of the Netherlands [...]
EORTC presentations at ESMO World Congress on Gastrointestinal Cancer
The EORTC will present one oral abstract and one poster [...]
SPECTAlung open to patient entry
The EORTC-ETOP cooperation has now successfully given rise to SPECTAlung, [...]
EORTC and Andaman7 are working together to develop Synchronized Health Records
Vincent Keunen (photo) runs the software development company that developed [...]
Current healthcare challenges force everyone to work together
Françoise Meunier Talks about the benefits of partnership among clinical [...]
EORTC opens prospective registry for patients with Melanoma
Sentinel node biopsy is the standard staging procedure for melanoma [...]
EORTC and Univ Oxford launch EUROSARC trial for patients with advanced Ewing Sarcoma
EUROSARC, European Clinical trials in Rare Sarcomas within an integrated [...]
RECIST news and updates
Hear Lesley Seymour and Jan Bogaerts discuss with Helen Saul [...]
DATECAN initiative publishes Guidelines for time-to-event end point definitions in breast cancer trials
The DATECAN initiative, Definition for the Assessment of Time-to-event Endpoints [...]
EORTC, through SPECTAlung, participates in EU consortium validating blood-based cancer biomarkers
Blood-based biomarkers such as circulating tumor cells (CTCs), circulating free [...]
